kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery
- Stroke
- Chronic Stroke Patients
- Arm Weakness as a Consequence of Stroke
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Magnetic Tides
- Enrolment target
- 6
- Started
- 1 October 2026
- Main results due
- 28 February 2027
- Study sites
- 1
- Registry updated
- 29 September 2026
Can you take part?
- Ages 18 years to 80 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion criteria: 1. Adults aged 18-80 years who have a history of an ischemic or hemorrhagic stroke ≥ 12 m prior to enrollment. 2. Fugl-Meyer Assessment: Upper Extremity (FMA UE) score 20-50. 3. Ability to communicate, understand, and give appropriate consent. Participants can follow two-step commands. 4. Motor evoked potentials in a hand muscle when stimulating ipsilesional cortex with suprathreshold single-pulse TMS (MEP positive). Exclusion criteria: 1. Participants with moderate or severe cognitive impairment (MMSE \< 18). 2. Participants with sensory deficits FMA-S \< 6/12 (with proprioception \< 4/8). 3. Participants with severe apraxia (TULIA \< 5). 4. Language impairment or behavioral disorder that interferes with their ability to adhere to the protocol or to provide informed consent. 5. Individuals who have a serious uncontrolled medical condition, including but not limited to severe cardiovascular and cardiopulmonary disease. 6. Pregnancy or plans to become pregnant during the study period. 7. Botulinum toxin injections of the affected upper extremity within 3 months prior to onset of study. 8. Severe spasticity of the affected upper limb (Modified Ashworth ≥ 4). 9. Absolute contraindications related to non-invasive brain stimulation, including: 9a) History of seizures in the last 12 months while taking anti-epilepsy medication 9b) Presence of any metal implants in the head (excluding the mouth), such as cortical stimulators and DBS, clips, coils, shunts, stents or skull plates, cochlear implants 9c) Permanent eye liner or head tattoos 9d) Implanted electronics such as pacemakers, defibrillators, intrathecal baclofen pumps or vagus nerve stimulator 9e) History of experiencing a serious adverse event during a previous transcranial magnetic stimulation (TMS) session
What this study is about
In the sponsor’s own words, from the registry.
kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.
Study sites(1)
UCSF Mission Bay- Sandler Neurosciences Center
San Francisco, California, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07631078. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me